Targeting the Fire Within: How InflaRx Is Redefining Inflammation Control
InflaRx CEO Dr. Niels Riedmann joins Rx for Biotech to discuss how the company is pioneering complement-directed therapies to control severe inflammation and autoimmune disease. We break down the science behind INF904, and why C5a is such a powerful immune driver, and how precision immunology is shaping the next wave of treatment innovation.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.